LC
TMCI icon

Lindbrook Capital’s Treace Medical Concepts TMCI Stock Holding History

Lindbrook Capital’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$3.36K Hold
401
– – ﹤0.01% 2113
2024
Q4 		$2.98K Buy
401
+151
+60% +$1.01K ﹤0.01% 2181
2024
Q3 		$1.45K Sell
250
-183
-42% -$1.18K ﹤0.01% 2426
2024
Q2 		$2.88K Buy
433
+399
+1,174% +$3.22K ﹤0.01% 2232
2024
Q1 		$444 Hold
34
– – ﹤0.01% 2528
2023
Q4 		$434 Sell
34
-38
-53% -$384 ﹤0.01% 2593
2023
Q3 		$944 Buy
72
+48
+200% +$879 ﹤0.01% 2372
2023
Q2 		$614 Hold
24
– – ﹤0.01% 2466
2023
Q1 		$605 Hold
24
– – ﹤0.01% 2573
2022
Q4 		$552 Buy
+24
New +$553 ﹤0.01% 2581

Other funds holding TMCI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Lindbrook Capital's TMCI Position: Q1 2025 in Review

Lindbrook Capital held its Treace Medical Concepts (TMCI) position steady in Q1 2025 at 401 shares worth $3.36K. The position accounts for ﹤0.01% of the portfolio, ranked #2113.

Lindbrook Capital first reported a position in TMCI in Q4 2022 and has held it in 10 quarters since. 138 funds tracked by Wall St. Rank hold TMCI as of Q1 2025.

  • Lindbrook Capital held 401 shares of Treace Medical Concepts worth $3.36K as of Q1 2025.
  • Lindbrook Capital left its Treace Medical Concepts share count unchanged in Q1 2025.
  • Treace Medical Concepts made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #2113 holding.
  • Lindbrook Capital first reported a position in Treace Medical Concepts in Q4 2022 and has held it in 10 quarters since.
  • 138 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.